Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Help for Deciding Who Should Get Herceptin

Article PDF
02808002e_0.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 28(8)
Publications
Federal Practitioner
Page Number
E2
Legacy Keywords
breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
02808002e_0.pdf
Article PDF
02808002e_0.pdf

Issue
Federal Practitioner - 28(8)
Issue
Federal Practitioner - 28(8)
Page Number
E2
Page Number
E2
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Help for Deciding Who Should Get Herceptin
Display Headline
Help for Deciding Who Should Get Herceptin
Legacy Keywords
breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17
Legacy Keywords
breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17breast cancer, HER2-positive, trastuzumab, Herceptin, genetic screening test, Inform Dual ISH, HER2 gene, tumor tissue, chromosome 17
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media